Articles  |   September 2017
Sufentanil Sublingual Tablet System Holds Promise as Alternative to I.V. PCA
Article Information
Pain Medicine / Pharmacology / Articles
Articles   |   September 2017
Sufentanil Sublingual Tablet System Holds Promise as Alternative to I.V. PCA
ASA Monitor 09 2017, Vol.81, 22-24.
ASA Monitor 09 2017, Vol.81, 22-24.
The following article was developed by ASA to introduce the ASA Monitor readership to the latest technology and advancements in the specialty. It should not be construed as an endorsement by ASA of any specific product or service.
Despite continued improvements in pain treatment, moderate to severe postoperative pain remains the focus of ongoing research in medicine. A retrospective study in 2003 by Apfelbaum et al. indicated that 35 percent of patients experienced severe postoperative pain at discharge and 22 percent reported severe pain two weeks post-discharge.1  A 2015 study by Buvanendran et al. found that 12 percent of surgical patients reported severe pain at discharge, with 13 percent reporting severe pain after two weeks.2  Although these numbers point to an encouraging improve-ment, the incidence of postsurgical pain remains unacceptably high. Postsurgical pain leads to overall decreased patient satisfaction, decreased mobility, increased costs of care, development of chronic pain and a host of other complications.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×